New Ti-6Al-2Nb-2Ta-1Mo alloy as implant biomaterial: in vitro corrosion and in vivo osseointegration evaluations
Date
2020Abstract
Over the last decade, new titanium alloys are developed in different areas of
implantology. The aim of this study was to characterize a new Ti-Al-Nb-Ta-Mo based alloy, with
high potential for being used as a biomedical implant. The evaluation of Ti-6Al-2Nb-2Ta-1Mo
was performed both in vitro (by monitoring its corrosion resistance in Hank’s Balanced Salt
Solution, HBSS) and in vivo (by evaluating the osseointegration following rabbit tibia
implantation), by comparison with titanium and Ti-6Al-7Nb alloy. Electrochemical impedance
spectroscopy (EIS) data showed high impedance values for all titanium samples after 1 week
immersion times in HBSS at 37 oC. According to EIS analysis, the corrosion resistance of the Ti-
6Al-2Nb-2Ta-1Mo alloy immersed in HBSS was higher compared to the standard cp-Ti or with
the Ti-6Al-7Nb alloy. In addition, a higher degree of osseointegration was achieved by the Ti-
6Al-2Nb-2Ta-1Mo alloy, thus probing that a higher resistance to electrochemical corrosion
provided enhanced protection to the implant surface against biodegradation, thus positively
affecting the qualitative and quantitative evolution of bone tissue repair.